DUAL ACTION
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 13 Jul 2023)
What this means for you
Registered since 04 Oct 2016. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86816258
- Registration number
- 5056145
- Mark type
- Design + words
- Filed
- 11 Nov 2015
- Published for opposition
- 10 May 2016
- Registered
- 04 Oct 2016
- Attorney of record
- Victoria Friedman
Goods and services
- Class 005 — Pharmaceuticals: antacids, acid-reducing preparations [, and pharmaceutical preparations for the treatment or alleviation of ulcers and gastrointestinal disorders ]
Owner
- CHATTEM, INC., CHATTANOOGA, TN, US
- Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, US
- Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, US
- Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, US
Prosecution history
- 04 Oct 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 13 Jul 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 13 Jul 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 13 Jul 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 18 Jan 2023 — TEAS SECTION 8 & 15 RECEIVED
- 04 Oct 2021 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 21 Jun 2017 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 04 Oct 2016 — REGISTERED-PRINCIPAL REGISTER
- 02 Sept 2016 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 01 Sept 2016 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 11 Aug 2016 — STATEMENT OF USE PROCESSING COMPLETE
- 07 Jul 2016 — USE AMENDMENT FILED
- 03 Aug 2016 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 07 Jul 2016 — TEAS STATEMENT OF USE RECEIVED
- 05 Jul 2016 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT